Literature DB >> 19401956

Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies.

Pauline M Maki1, Julie Dumas.   

Abstract

Use of estrogen therapy in the perimenopausal and postmenopausal periods has been shown in several clinical trials to help women maintain a premenopausal level of cognitive function. What is not yet fully understood is how the neurobiological effects of estrogen contribute to these cognitive effects. This review explores data from two related bodies of human literature that provide compelling evidence in support of the biological plausibility that estrogen treatment can benefit cognition. The first half of the literature review focuses on studies from the estrogen neuroimaging literature, and the second half focuses on pharmacologic challenge studies assessing estrogen-neurotransmitter interactions. We integrate these two bodies of literature by focusing on the neurophysiologic underpinnings of estrogen effects on cognition and linking these clinical studies to preclinical studies. The focus on verbal memory is important because it is a cognitive function that has been shown to change with estrogen treatment and predict Alzheimer's disease risk but is not addressed by preclinical studies. Overall, we conclude that estrogen interacts with cholinergic and serotonergic systems to affect hippocampal and frontal cortical brain areas and thereby enhance memory, particularly at the retrieval stage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401956      PMCID: PMC4999426          DOI: 10.1055/s-0029-1216278

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  66 in total

1.  Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation.

Authors:  C E Gleason; T W Schmitz; T Hess; R L Koscik; M A Trivedi; M L Ries; C M Carlsson; M A Sager; S Asthana; S C Johnson
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

2.  Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.

Authors:  L Linzmayer; H V Semlitsch; B Saletu; G Böck; G Saletu-Zyhlarz; A Zoghlami; D Gruber; M Metka; J Huber; M Oettel; T Gräser; J Grünberger
Journal:  Arzneimittelforschung       Date:  2001

Review 3.  The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?

Authors:  B B Sherwin
Journal:  J Neuroendocrinol       Date:  2007-02       Impact factor: 3.627

4.  Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women.

Authors:  Miglena Grigorova; Barbara B Sherwin; Togas Tulandi
Journal:  Psychoneuroendocrinology       Date:  2006-07-10       Impact factor: 4.905

5.  Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism.

Authors:  N R Varney; C Syrop; C S Kubu; M Struchen; S Hahn; K Franzen
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

Review 6.  Pharmacologic modelling of Alzheimer's disease.

Authors:  T Sunderland; P N Tariot; H Weingartner; D L Murphy; P A Newhouse; E A Mueller; R M Cohen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1986       Impact factor: 5.067

Review 7.  Hormone therapy and cognitive function: is there a critical period for benefit?

Authors:  P M Maki
Journal:  Neuroscience       Date:  2006-02-20       Impact factor: 3.590

Review 8.  Estrogen and SERM neuroprotection in animal models of Parkinson's disease.

Authors:  Marc Morissette; Sara Al Sweidi; Sophie Callier; Thérèse Di Paolo
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

9.  Effects of combination estrogen plus progestin hormone treatment on cognition and affect.

Authors:  Susan M Resnick; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Robert Brunner; Laura H Coker; Iris A Granek; Patricia Hogan; Judith K Ockene; Sally A Shumaker
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

Review 10.  Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings.

Authors:  E Tulving; S Kapur; F I Craik; M Moscovitch; S Houle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  18 in total

1.  Reproductive experience alters neural and behavioural responses to acute oestrogen receptor α activation.

Authors:  E M Byrnes; K Casey; L M Carini; R S Bridges
Journal:  J Neuroendocrinol       Date:  2013-12       Impact factor: 3.627

2.  Hormonal environment affects cognition independent of age during the menopause transition.

Authors:  Alison Berent-Spillson; Carol C Persad; Tiffany Love; MaryFran Sowers; John F Randolph; Jon-Kar Zubieta; Yolanda R Smith
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

3.  Adiposity-related insulin resistance and thickness of the cerebral cortex in middle-aged adults.

Authors:  Jean Shin; Stephanie Pelletier; Louis Richer; G Bruce Pike; Daniel Gaudet; Tomas Paus; Zdenka Pausova
Journal:  J Neuroendocrinol       Date:  2020-12       Impact factor: 3.627

4.  Cerebrovascular reactivity across the menstrual cycle in young healthy women.

Authors:  J Krejza; W Rudzinski; M Arkuszewski; O Onuoha; E R Melhem
Journal:  Neuroradiol J       Date:  2013-08-27

5.  Estrogen enhances hippocampal gray-matter volume in young and older postmenopausal women: a prospective dose-response study.

Authors:  Kimberly Albert; Jessica Hiscox; Brian Boyd; Julie Dumas; Warren Taylor; Paul Newhouse
Journal:  Neurobiol Aging       Date:  2017-04-08       Impact factor: 4.673

6.  Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders.

Authors:  Federico Rodriguez-Porcel; Donald Green; Nidhi Khatri; Sharonda Swilley Harris; Warren L May; Rick C S Lin; Ian A Paul
Journal:  Anat Rec (Hoboken)       Date:  2011-09-08       Impact factor: 2.064

Review 7.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

8.  Cognition in perimenopause: the effect of transition stage.

Authors:  Miriam T Weber; Leah H Rubin; Pauline M Maki
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

Review 9.  Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.

Authors:  Pauline M Maki
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

10.  Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?

Authors:  Catherine M Bender; Susan M Sereika; Christopher M Ryan; Adam M Brufsky; Shannon Puhalla; Sarah L Berga
Journal:  Menopause       Date:  2013-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.